Oncovita

Developer of virus-derived vaccine technology to treat cancer

placeParis, Ile De France, France calendar_todayFounded 2015 groups2 employees language oncovita.fr

Innovation

1 patent family — focus: Human necessities; filing pace active. Cited 44 times.

YearFilings
20261

Social engagement

Social engagement: 1.2K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Bank & private debt1100%

Recent activity

29 Jun 2026
Event
BIO International Convention 2026
26 Jun 2026
Partnership
Infinitusbio.AI and ITJ teams
4 Jun 2026
Event
EACR Annual Congress 2026
Coming soon